Lab
Quest Diagnostics Clinical Laboratories INC
Quest Diagnostics Clinical Laboratories INC was paid $2.00M by Medicaid between Jan 2018 and Apr 2024, across 176 billing codes. Its largest line is 80050, General health panel — 8.0% of everything it billed.
33Billing provider infoQUEST DIAGNOSTICS CLINICAL LABORATORIES INC
MELVILLE, NY 11747
MELVILLE, NY 11747
33aNPI1225074065assigned 06/21/2006
33bProvider typeClinical Medical Laboratory
28Total paid$2.00M
24GClaims221,726
24DCodes billed176
24AFirst – last monthJan 2018 – Apr 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in New York
Rank by total paid#46 of 116
Median peer was paid$618K
This provider vs. median3.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TIMMERMAN, LEAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,015 | $79K | |
| 2019 | 36,311 | $190K | |
| 2020 | 23,547 | $193K | |
| 2021 | 6,451 | $76K | |
| 2022 | 30,929 | $327K | |
| 2023 | 92,169 | $971K | |
| 2024incomplete | 15,304 | $167K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80050 | General health panel | 8.0% | 7,440 | 7,435 | $160K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.5% | 6,500 | 6,490 | $130K |
| 86480 | 6.5% | 3,127 | 3,119 | $130K | |
| 80061 | Lipid panel | 5.4% | 15,246 | 15,188 | $109K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.8% | 3,968 | 1,715 | $96K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.0% | 6,992 | 6,794 | $80K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.9% | 6,896 | 6,698 | $78K |
| 80053 | Comprehensive metabolic panel | 3.8% | 13,487 | 13,152 | $77K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.5% | 11,416 | 11,373 | $71K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 609 | 581 | $56K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 12,436 | 12,205 | $48K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.3% | 3,282 | 3,277 | $47K |
164 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 2.3% | 5,623 | $47K |
| 82607 | 2.2% | 4,971 | $43K | |
| 86769 | 2.1% | 1,133 | $42K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.0% | 1,415 | $40K |
| 81513 | 2.0% | 259 | $40K | |
| 82746 | 1.4% | 3,309 | $28K | |
| 85027 | 1.4% | 7,570 | $27K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.3% | 4,155 | $27K |
| 86364 | 1.2% | 257 | $24K | |
| 81001 | 1.2% | 11,295 | $24K | |
| 84439 | 1.1% | 4,169 | $23K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.1% | 5,936 | $22K |
| 84153 | 1.1% | 1,935 | $21K | |
| 82728 | 1.1% | 3,051 | $21K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,783 | $20K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 307 | $19K |
| 86003 | <1% | 247 | $18K | |
| 83655 | <1% | 2,034 | $17K | |
| 86803 | <1% | 1,992 | $17K | |
| 88185 | <1% | 55 | $14K | |
| 87340 | <1% | 2,185 | $13K | |
| 87088 | <1% | 2,387 | $13K | |
| 86901 | <1% | 6,280 | $13K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 288 | $13K |
| 83550 | <1% | 2,869 | $12K | |
| 83540 | <1% | 3,261 | $11K | |
| 80357 | <1% | 855 | $10K | |
| 82652 | <1% | 449 | $9K | |
| 83013 | <1% | 210 | $9K | |
| 86592 | <1% | 3,205 | $8K | |
| 86762 | <1% | 946 | $8K | |
| 86765 | <1% | 1,008 | $8K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 65 | $8K |
| 86735 | <1% | 951 | $8K | |
| 86696 | <1% | 551 | $8K | |
| 86787 | <1% | 855 | $7K | |
| 87631 | <1% | 83 | $7K | |
| 86706 | <1% | 1,051 | $7K | |
| 80349 | <1% | 577 | $7K | |
| 84403 | <1% | 432 | $7K | |
| 82043 | <1% | 1,959 | $6K | |
| 87081 | <1% | 1,470 | $6K | |
| 82570 | <1% | 2,026 | $6K | |
| 87517 | <1% | 221 | $6K | |
| 84550 | <1% | 2,416 | $5K | |
| 86708 | <1% | 728 | $5K | |
| 84702 | <1% | 609 | $5K | |
| 84481 | <1% | 450 | $5K | |
| 82784 | <1% | 496 | $4K | |
| 84436 | <1% | 1,162 | $4K | |
| 83001 | <1% | 378 | $4K | |
| 86704 | <1% | 609 | $4K | |
| 86038 | <1% | 586 | $4K | |
| 88141 | <1% | 280 | $4K | |
| 82274 | <1% | 471 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 893 | $4K |
| 82248 | <1% | 1,303 | $4K | |
| 83002 | <1% | 322 | $4K | |
| 87070 | <1% | 684 | $4K | |
| 84480 | <1% | 429 | $4K | |
| 86140 | <1% | 1,138 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 693 | $3K |
| 82670 | <1% | 206 | $3K | |
| 82105 | <1% | 361 | $3K | |
| 86376 | <1% | 376 | $3K | |
| 84154 | <1% | 297 | $3K | |
| 84479 | <1% | 884 | $3K | |
| 86800 | <1% | 323 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 123 | $3K |
| 84146 | <1% | 257 | $3K | |
| 83520 | <1% | 377 | $3K | |
| 87799 | <1% | 43 | $3K | |
| 88142 | <1% | 374 | $3K | |
| 83735 | <1% | 994 | $3K | |
| 87186 | <1% | 548 | $3K | |
| 87077 | <1% | 545 | $3K | |
| 82785 | <1% | 249 | $2K | |
| 84402 | <1% | 164 | $2K | |
| 86300 | <1% | 232 | $2K | |
| 83020 | <1% | 306 | $2K | |
| 82550 | <1% | 634 | $2K | |
| 82378 | <1% | 264 | $2K | |
| 88189 | <1% | 63 | $2K | |
| 87147 | <1% | 614 | $2K | |
| 88184 | <1% | 68 | $2K | |
| 86334 | <1% | 166 | $2K | |
| 85652 | <1% | 1,030 | $2K | |
| 86141 | <1% | 218 | $2K | |
| 86900 | <1% | 884 | $2K | |
| 83615 | <1% | 729 | $2K | |
| 86850 | <1% | 654 | $2K | |
| 86235 | <1% | 41 | $2K | |
| 82977 | <1% | 341 | $1K | |
| 84100 | <1% | 745 | $1K | |
| 83970 | <1% | 63 | $1K | |
| 80076 | <1% | 274 | $1K | |
| 81003 | <1% | 971 | $1K | |
| 82627 | <1% | 90 | $1K | |
| 85610 | <1% | 563 | $1K | |
| 80321 | <1% | 70 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 12 | $1K |
| 86431 | <1% | 305 | $1K | |
| 87512 | <1% | 43 | $960.26 | |
| 82668 | <1% | 106 | $922.23 | |
| 86036 | <1% | 12 | $857.16 | |
| 86618 | <1% | 79 | $798.76 | |
| 85730 | <1% | 235 | $792.15 | |
| 84156 | <1% | 370 | $763.32 | |
| 87150 | <1% | 35 | $758.45 | |
| 80081 | <1% | 15 | $693.45 | |
| 86317 | <1% | 85 | $691.57 | |
| 86301 | <1% | 54 | $656.74 | |
| 87522 | Neg quan hep c or qual rna | <1% | 26 | $634.56 |
| 87209 | <1% | 44 | $588.30 | |
| 86304 | <1% | 52 | $526.84 | |
| 88112 | <1% | 30 | $465.30 | |
| 86665 | <1% | 24 | $460.25 | |
| 82465 | <1% | 143 | $412.55 | |
| 84144 | <1% | 32 | $412.48 | |
| 80074 | <1% | 15 | $411.74 | |
| 84165 | <1% | 92 | $388.73 | |
| 88304 | <1% | 126 | $382.16 | |
| 87481 | <1% | 12 | $380.96 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 36 | $369.00 |
| 83690 | <1% | 79 | $320.46 | |
| 86225 | <1% | 37 | $315.69 | |
| 85651 | <1% | 175 | $297.57 | |
| 87177 | <1% | 44 | $291.50 | |
| 85045 | <1% | 141 | $277.24 | |
| 83010 | <1% | 52 | $275.31 | |
| 86617 | <1% | 13 | $248.56 | |
| 82232 | <1% | 29 | $247.22 | |
| 82150 | <1% | 63 | $240.91 | |
| 82950 | <1% | 80 | $233.60 | |
| 86021 | <1% | 26 | $232.50 | |
| 87338 | <1% | 27 | $230.62 | |
| 83525 | <1% | 31 | $211.50 | |
| 80348 | <1% | 14 | $192.50 | |
| 80362 | <1% | 20 | $189.38 | |
| 83021 | <1% | 27 | $181.85 | |
| 84460 | <1% | 57 | $179.85 | |
| 84450 | <1% | 53 | $163.20 | |
| 84270 | <1% | 12 | $161.04 | |
| 80373 | <1% | 14 | $155.96 | |
| 87660 | <1% | 13 | $125.64 | |
| 87480 | <1% | 13 | $125.64 | |
| 87510 | <1% | 13 | $125.64 | |
| 83090 | <1% | 12 | $114.62 | |
| 82040 | <1% | 36 | $107.10 | |
| 82247 | <1% | 31 | $89.61 | |
| 87449 | <1% | 12 | $88.80 | |
| 86707 | <1% | 14 | $85.80 | |
| 87350 | <1% | 14 | $85.44 | |
| 84075 | <1% | 27 | $83.20 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 326 | $80.50 |
| 81025 | <1% | 15 | $58.65 | |
| 81015 | <1% | 28 | $50.49 | |
| 85018 | <1% | 58 | $49.87 | |
| 85014 | <1% | 55 | $46.96 | |
| 85041 | <1% | 39 | $42.23 | |
| 82310 | <1% | 14 | $41.47 | |
| 82947 | <1% | 14 | $34.16 | |
| 85048 | <1% | 13 | $15.85 | |
| 99080 | 0% | 135 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTIMMERMAN, LEAH (VICE PRESIDENT)
Parent organizationQUEST DIAGNOSTICS INCORPORATED
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.